Located at The Princess Margaret Cancer Centre
Cancer research is the priority at the Ontario Cancer Institute (OCI), one of the University Health Network's five research institutes.
Researchers here employ state-of-the-art tools in genomics, proteomics, structural biology, molecular biology, biophysics and the behavioural sciences.
With these tools they analyze cancerous cells at the molecular level; test gene and cellular therapies for cancer and other diseases; develop new technologies for diagnosing and treating cancer; determine the effects of diet and behaviour on cancer risks; and develop and test informatics tools for the large-scale analysis of patient populations.
Advanced Medical Discovery Institute
Part of OCI, the Advanced Medical Discovery Institute focuses on the development of transgenic mouse models for disorders of cell growth and the immune system. It is led by Dr. Tak Mak, who is world-renowned for his cloning of the human T cell receptor.
The Campbell Family Cancer Research Institute
The newest addition to OCI, this institute will accelerate the pace of breakthrough cancer research, facilitating the translation of cancer discoveries into new life-saving therapies and more personalized cancer treatments for each patient. The Campbell Family Cancer Research Institute is headed by OCI Director Dr. Benjamin Neel, a leading authority on cancer cell research who was recruited from Harvard Medical School in the fall of 2006.
The Campbell Family Institute for Breast Cancer Research
Recognizing the need to combat the most common cancer in Canadian women, this institute focuses on developing the next generation of treatments for breast cancer patients. Led by internationally recognized scientist Dr. Tak Mak, The Campbell Family Institute
for Breast Cancer Research
joins together basic, translational and clinical research and will focus on developing new drugs and therapies that are more effective, less toxic and can increase a patient’s quality and length of life.